167 related articles for article (PubMed ID: 35268738)
1. Jusanin, a New Flavonoid from
Suleimen YM; Jose RA; Suleimen RN; Arenz C; Ishmuratova MY; Toppet S; Dehaen W; Alsfouk BA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Mar; 27(5):. PubMed ID: 35268738
[TBL] [Abstract][Full Text] [Related]
2. Isolation and In Silico SARS-CoV-2 Main Protease Inhibition Potential of Jusan Coumarin, a New Dicoumarin from
Suleimen YM; Jose RA; Suleimen RN; Ishmuratova MY; Toppet S; Dehaen W; Alsfouk AA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408682
[TBL] [Abstract][Full Text] [Related]
3. Isolation and In Silico Anti-SARS-CoV-2 Papain-Like Protease Potentialities of Two Rare 2-Phenoxychromone Derivatives from
Suleimen YM; Jose RA; Suleimen RN; Arenz C; Ishmuratova M; Toppet S; Dehaen W; Alsfouk AA; Elkaeed EB; Eissa IH; Metwaly AM
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209006
[TBL] [Abstract][Full Text] [Related]
4. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
5. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach.
Gupta Y; Kumar S; Zak SE; Jones KA; Upadhyay C; Sharma N; Azizi SA; Kathayat RS; Poonam ; Herbert AS; Durvasula R; Dickinson BC; Dye JM; Rathi B; Kempaiah P
Bioorg Med Chem; 2021 Oct; 47():116393. PubMed ID: 34509862
[TBL] [Abstract][Full Text] [Related]
6. Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease.
Gogoi N; Chowdhury P; Goswami AK; Das A; Chetia D; Gogoi B
Mol Divers; 2021 Aug; 25(3):1745-1759. PubMed ID: 33236176
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach.
El Bakri Y; Anouar EH; Ahmad S; Nassar AA; Taha ML; Mague JT; El Ghayati L; Essassi EM
Appl Biochem Biotechnol; 2021 Nov; 193(11):3602-3623. PubMed ID: 34324152
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.
Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G
Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935
[TBL] [Abstract][Full Text] [Related]
9. Phytoconstituents of Artemisia Annua as potential inhibitors of SARS CoV2 main protease: an in silico study.
Irfan E; Dilshad E; Ahmad F; Almajhdi FN; Hussain T; Abdi G; Waheed Y
BMC Infect Dis; 2024 May; 24(1):495. PubMed ID: 38750422
[TBL] [Abstract][Full Text] [Related]
10. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
11. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.
Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K
Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605
[TBL] [Abstract][Full Text] [Related]
12. Molecular Docking Studies of Bioactive Nicotiflorin against 6W63 Novel Coronavirus 2019 (COVID-19).
Dubey R; Dubey K
Comb Chem High Throughput Screen; 2021; 24(6):874-878. PubMed ID: 33109057
[TBL] [Abstract][Full Text] [Related]
13. A Multistage In Silico Study of Natural Potential Inhibitors Targeting SARS-CoV-2 Main Protease.
Elkaeed EB; Eissa IH; Elkady H; Abdelalim A; Alqaisi AM; Alsfouk AA; Elwan A; Metwaly AM
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955547
[TBL] [Abstract][Full Text] [Related]
14.
Eissa IH; Khalifa MM; Elkaeed EB; Hafez EE; Alsfouk AA; Metwaly AM
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684735
[TBL] [Abstract][Full Text] [Related]
15. Virtual Screening of
Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
[TBL] [Abstract][Full Text] [Related]
17. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
Hajbabaie R; Harper MT; Rahman T
Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
[TBL] [Abstract][Full Text] [Related]
18. In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.
Ibrahim MAA; Abdelrahman AHM; Allemailem KS; Almatroudi A; Moustafa MF; Hegazy MF
Protein J; 2021 Jun; 40(3):296-309. PubMed ID: 33387249
[TBL] [Abstract][Full Text] [Related]
19.
Rudrapal M; Issahaku AR; Agoni C; Bendale AR; Nagar A; Soliman MES; Lokwani D
J Biomol Struct Dyn; 2022; 40(20):10437-10453. PubMed ID: 34182889
[TBL] [Abstract][Full Text] [Related]
20. Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease.
Basu S; Veeraraghavan B; Ramaiah S; Anbarasu A
Microb Pathog; 2020 Dec; 149():104546. PubMed ID: 33011363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
